Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions

BACKGROUND: In March 2020, following a provincial COVID-19 emergency declaration, modifications to opioid agonist treatment (OAT) were introduced in Ontario, Canada to promote treatment access amid the pandemic and ongoing opioid overdose crisis. Modifications included federal exemptions to facilita...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouck, Zachary, Scheim, Ayden I., Gomes, Tara, Ling, Vicki, Caudarella, Alexander, Werb, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005368/
https://www.ncbi.nlm.nih.gov/pubmed/35447476
http://dx.doi.org/10.1016/j.drugpo.2022.103680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005368/
https://www.ncbi.nlm.nih.gov/pubmed/35447476
http://dx.doi.org/10.1016/j.drugpo.2022.103680

Ejemplares similares